{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2016-N-0832\" sorted by posted_date descending", "rows": [["FDA-2016-N-0832-0072", "FDA", "FDA-2016-N-0832", "Letter to Commissioner Hahn Opposing CVM Proposal", "Other", "Letter(s)", "2020-07-28T04:00:00Z", 2020, 7, "2020-07-28T04:00:00Z", null, "2020-08-13T17:15:14Z", null, 0, 0, "09000064847aecb6"], ["FDA-2016-N-0832-0074", "FDA", "FDA-2016-N-0832", "FDA Memorandum regarding the Separation of Functions for Carbadox", "Other", "Memorandum", "2020-07-28T04:00:00Z", 2020, 7, "2020-07-28T04:00:00Z", null, "2020-07-28T15:05:04Z", null, 0, 0, "09000064847aecb8"], ["FDA-2016-N-0832-0073", "FDA", "FDA-2016-N-0832", "Carbadox Letter July 17 2020 Final (003)", "Other", "Letter(s)", "2020-07-28T04:00:00Z", 2020, 7, "2020-07-28T04:00:00Z", null, "2020-08-13T17:15:42Z", null, 0, 0, "09000064847aecb7"], ["FDA-2016-N-0832-0069", "FDA", "FDA-2016-N-0832", "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Revocation\nof Approved Method", "Notice", "Proposed Guidelines", "2020-07-20T04:00:00Z", 2020, 7, "2020-07-20T04:00:00Z", "2020-07-21T03:59:59Z", "2020-08-14T15:22:36Z", "2020-15246", 0, 0, "090000648478618d"], ["FDA-2016-N-0832-0070", "FDA", "FDA-2016-N-0832", "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Withdrawal\nof Notice of Opportunity for Hearing", "Notice", "Withdrawal", "2020-07-20T04:00:00Z", 2020, 7, "2020-07-20T04:00:00Z", null, "2020-07-20T14:42:56Z", "2020-15245", 0, 0, "0900006484786227"], ["FDA-2016-N-0832-0068", "FDA", "FDA-2016-N-0832", "Letter from FDA CVM to Phibro Animal Health Corporation", "Other", "Letter(s)", "2020-07-17T04:00:00Z", 2020, 7, "2020-07-17T04:00:00Z", null, "2020-08-13T17:01:02Z", null, 0, 0, "090000648477e2ca"], ["FDA-2016-N-0832-0067", "FDA", "FDA-2016-N-0832", "Sixth Joint Status Report", "Other", "Report", "2020-04-30T04:00:00Z", 2020, 4, "2020-04-30T04:00:00Z", null, "2020-04-30T12:50:21Z", null, 0, 0, "0900006484520418"], ["FDA-2016-N-0832-0066", "FDA", "FDA-2016-N-0832", "Joint Status Report 5 - FINAL 12-20-19", "Other", "Report", "2019-12-20T05:00:00Z", 2019, 12, "2019-12-20T05:00:00Z", null, "2019-12-20T15:18:16Z", null, 0, 0, "0900006484240783"], ["FDA-2016-N-0832-0065", "FDA", "FDA-2016-N-0832", "Joint Status Report 4- Final 8-29-19", "Other", "Report", "2019-08-29T04:00:00Z", 2019, 8, "2019-08-29T04:00:00Z", null, "2019-08-29T18:28:13Z", null, 0, 0, "0900006483edac12"], ["FDA-2016-N-0832-0064", "FDA", "FDA-2016-N-0832", "Third Joint Status Report - Notice of Opportunity for Hearing: Proposal to Withdraw Approval of New Animal Drug Applications for Carbadox in Medicated Swine Feed", "Other", "Report", "2019-04-30T04:00:00Z", 2019, 4, "2019-04-30T04:00:00Z", null, "2019-04-30T15:02:03Z", null, 0, 0, "0900006483c1df0f"], ["FDA-2016-N-0832-0063", "FDA", "FDA-2016-N-0832", "Memorandum from Denish M. Hinton to FDA DDM", "Other", "Memorandum", "2019-03-20T04:00:00Z", 2019, 3, "2019-03-20T04:00:00Z", null, "2019-03-20T14:03:45Z", null, 0, 0, "0900006483b06656"], ["FDA-2016-N-0832-0062", "FDA", "FDA-2016-N-0832", "Second Joint Status Report re Carbadox", "Other", "Report", "2018-12-21T05:00:00Z", 2018, 12, "2018-12-21T05:00:00Z", null, "2018-12-21T15:02:23Z", null, 0, 0, "09000064839bea66"], ["FDA-2016-N-0832-0061", "FDA", "FDA-2016-N-0832", "Joint Status Report 1 Final 8-31-18", "Other", "Report", "2018-08-31T04:00:00Z", 2018, 8, "2018-08-31T04:00:00Z", null, "2018-08-31T13:28:59Z", null, 0, 0, "090000648368487d"], ["FDA-2016-N-0832-0060", "FDA", "FDA-2016-N-0832", "Carbadox Letter March 30 18", "Other", "Letter(s)", "2018-04-02T04:00:00Z", 2018, 4, "2018-04-02T04:00:00Z", null, "2018-04-02T13:27:35Z", null, 0, 0, "0900006483085912"], ["FDA-2016-N-0832-0059", "FDA", "FDA-2016-N-0832", "Letter from Covington to FDA", "Other", "Letter(s)", "2018-03-30T04:00:00Z", 2018, 3, "2018-03-30T04:00:00Z", null, "2018-03-30T16:34:05Z", null, 0, 0, "090000648307537a"], ["FDA-2016-N-0832-0058", "FDA", "FDA-2016-N-0832", "Legal and FDA Reference Material: Letter, CVM Request to Director Warren 3-16-18", "Other", "Request for Extension", "2018-03-21T04:00:00Z", 2018, 3, null, null, "2018-04-03T13:45:07Z", null, 0, 0, "090000648302a2a0"], ["FDA-2016-N-0832-0057", "FDA", "FDA-2016-N-0832", "Letter from Phibro Animal Health Corporation", "Other", "Letter(s)", "2017-12-29T05:00:00Z", 2017, 12, "2017-12-29T05:00:00Z", null, "2017-12-29T15:57:53Z", null, 0, 0, "0900006482d83a18"], ["FDA-2016-N-0832-0056", "FDA", "FDA-2016-N-0832", "Letter from FDA to Covington & Burling, LLP - Extention letter", "Other", "Extension of Time", "2017-12-20T05:00:00Z", 2017, 12, "2017-12-20T05:00:00Z", null, "2017-12-20T20:00:06Z", null, 0, 0, "0900006482d43d53"], ["FDA-2016-N-0832-0055", "FDA", "FDA-2016-N-0832", "Letter from FDA to Phibro Animal Health Corporation", "Other", "Letter(s)", "2017-10-31T04:00:00Z", 2017, 10, "2017-10-31T04:00:00Z", null, "2017-10-31T13:43:18Z", null, 0, 0, "0900006482c291cc"], ["FDA-2016-N-0832-0054", "FDA", "FDA-2016-N-0832", "Information Request Letter to Phibro (Covington and Burling)7-12-17", "Other", "Request", "2017-07-24T04:00:00Z", 2017, 7, "2017-07-24T04:00:00Z", null, "2017-07-24T14:44:46Z", null, 0, 0, "090000648291374d"], ["FDA-2016-N-0832-0053", "FDA", "FDA-2016-N-0832", "Carbadox Letter May 1", "Other", "Response(s)", "2017-05-02T04:00:00Z", 2017, 5, "2017-05-02T04:00:00Z", null, "2017-05-02T21:04:49Z", null, 0, 0, "090000648258bedb"], ["FDA-2016-N-0832-0052", "FDA", "FDA-2016-N-0832", "Confidential Letter from Center for Veterinary Medicine Recommendation to the Office of Scientific Integrity", "Other", "Response(s)", "2017-04-25T04:00:00Z", 2017, 4, "2017-04-25T04:00:00Z", null, "2017-04-25T16:52:07Z", null, 0, 0, "0900006482559998"], ["FDA-2016-N-0832-0051", "FDA", "FDA-2016-N-0832", "Letter from FDA to Covington & Burling LLP", "Other", "Letter(s)", "2017-03-17T04:00:00Z", 2017, 3, "2017-03-17T04:00:00Z", null, "2017-03-17T15:53:52Z", null, 0, 0, "0900006482510858"], ["FDA-2016-N-0832-0048", "FDA", "FDA-2016-N-0832", "Letter from Office of the General Counsel to FDA OC and Covington & Burling, LLP (Phibro)", "Other", "Letter(s)", "2017-03-14T04:00:00Z", 2017, 3, "2017-03-14T04:00:00Z", null, "2017-03-14T20:06:05Z", null, 0, 0, "09000064825077d6"], ["FDA-2016-N-0832-0050", "FDA", "FDA-2016-N-0832", "Letter from FDA Office of Scientific Integrity to Covington & Burling, LLP (Phibro) and Office of the Chief Counsel", "Other", "Letter(s)", "2017-03-14T04:00:00Z", 2017, 3, "2017-03-14T04:00:00Z", null, "2017-03-14T20:29:29Z", null, 0, 0, "09000064825077d8"], ["FDA-2016-N-0832-0049", "FDA", "FDA-2016-N-0832", "Follow up emails between FDA and Covington & Burling, LLP (Phibro)", "Other", "General Correspondence", "2017-03-14T04:00:00Z", 2017, 3, "2017-03-14T04:00:00Z", null, "2017-03-14T20:13:15Z", null, 0, 0, "09000064825077d7"], ["FDA-2016-N-0832-0047", "FDA", "FDA-2016-N-0832", "Letter from Covington & Burling LLP (Phibro) to FDA OC", "Other", "Letter(s)", "2017-03-14T04:00:00Z", 2017, 3, "2017-03-14T04:00:00Z", null, "2017-03-14T20:00:44Z", null, 0, 0, "09000064825077d5"], ["FDA-2016-N-0832-0046", "FDA", "FDA-2016-N-0832", "Letter granting CVM's request for an extension", "Other", "Letter(s)", "2016-11-29T05:00:00Z", 2016, 11, "2016-11-29T05:00:00Z", null, "2016-11-29T15:18:48Z", null, 0, 0, "09000064823c6e21"], ["FDA-2016-N-0832-0045", "FDA", "FDA-2016-N-0832", "Letter to Petitioner", "Other", "Letter(s)", "2016-10-05T04:00:00Z", 2016, 10, "2016-10-05T04:00:00Z", null, "2016-10-05T16:54:57Z", null, 0, 0, "090000648229bd86"], ["FDA-2016-N-0832-0040", "FDA", "FDA-2016-N-0832", "Exhibit 2 Expert Opinion of David H. Bechtel, Ph.D., D.A.B.T. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV", "Supporting & Related Material", "Background Material", "2016-07-15T04:00:00Z", 2016, 7, null, null, "2016-07-15T15:59:53Z", null, 0, 0, "09000064820b5e32"], ["FDA-2016-N-0832-0043", "FDA", "FDA-2016-N-0832", "Exhibit 7 Expert Opinion of Stephen Scypinski, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV", "Supporting & Related Material", "Background Material", "2016-07-15T04:00:00Z", 2016, 7, null, null, "2016-07-15T16:00:57Z", null, 0, 0, "09000064820b5e35"], ["FDA-2016-N-0832-0042", "FDA", "FDA-2016-N-0832", "Exhibit 4 Expert Opinion of John G. Dorsey, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV", "Supporting & Related Material", "Background Material", "2016-07-15T04:00:00Z", 2016, 7, null, null, "2016-07-15T16:00:01Z", null, 0, 0, "09000064820b5e34"], ["FDA-2016-N-0832-0041", "FDA", "FDA-2016-N-0832", "Exhibit 3 Expert Opinion of Neil. Kelleher, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV", "Supporting & Related Material", "Background Material", "2016-07-15T04:00:00Z", 2016, 7, null, null, "2016-07-15T15:59:56Z", null, 0, 0, "09000064820b5e33"], ["FDA-2016-N-0832-0044", "FDA", "FDA-2016-N-0832", "Exhibit 8 Expert Opinion of Robert D. Gibbons, Ph.D. re: Request for Hearing from Phibro Animal Health Corporation Redacted CV", "Supporting & Related Material", "Background Material", "2016-07-15T04:00:00Z", 2016, 7, null, null, "2016-07-15T16:01:58Z", null, 0, 0, "09000064820b5e36"], ["FDA-2016-N-0832-0038", "FDA", "FDA-2016-N-0832", "Exhibit 20 Corey Grass, C. F. Grass Consulting, Impact & Cost if Mecadox Was Not Available (June 2016) re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:58:17Z", null, 0, 0, "09000064820a3173"], ["FDA-2016-N-0832-0031", "FDA", "FDA-2016-N-0832", "Exhibit 6 FDA Location Directory (July 1990)  re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:07Z", null, 0, 0, "09000064820a3165"], ["FDA-2016-N-0832-0036", "FDA", "FDA-2016-N-0832", "Exhibit 14 M. Karlsson, et al Decreased Susceptibility to\nTiamulin in German Isolates of Brachyspira hyodysenteriae (Paper 43), Proc. 17th Int. Pig Vet. Soc. Cong., Ames, Iowa (2002) re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:57Z", null, 0, 0, "09000064820a316d"], ["FDA-2016-N-0832-0030", "FDA", "FDA-2016-N-0832", "Exhibit 5 Proceedings of the EuroResidue Conference, Noorwijkerhout re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:56:58Z", null, 0, 0, "09000064820a3111"], ["FDA-2016-N-0832-0032", "FDA", "FDA-2016-N-0832", "Exhibit 9 Declaration of Paul Duquette re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:18Z", null, 0, 0, "09000064820a3168"], ["FDA-2016-N-0832-0033", "FDA", "FDA-2016-N-0832", "Exhibit 10 Declaration of Kevin Bynum re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:26Z", null, 0, 0, "09000064820a3169"], ["FDA-2016-N-0832-0035", "FDA", "FDA-2016-N-0832", "Exhibit 12 R. Korty, et al A Cost Effective Alternative to Finishing Depopulation for Swine Dysentery, Am. Ass. Swine Vet. re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:48Z", null, 0, 0, "09000064820a316b"], ["FDA-2016-N-0832-0037", "FDA", "FDA-2016-N-0832", "Exhibit 15 A.C.J. Gresham, et al Treatment of Swine Dysentery Problems of Antibiotic Resistance and Concurrent Salmonellosis, 143 Vet. Rec. 619 (1998) re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:58:07Z", null, 0, 0, "09000064820a316e"], ["FDA-2016-N-0832-0034", "FDA", "FDA-2016-N-0832", "Exhibit 11 John C.S. Harding, Emergence of\"Brachyspira hampsonii\" in Western Canada: A Collaborative Success, Am. Ass. Swine Vet. 12-21 (2016) re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:57:39Z", null, 0, 0, "09000064820a316a"], ["FDA-2016-N-0832-0039", "FDA", "FDA-2016-N-0832", "Exhibit 21 Timeline April 2015 to April 2016: Summary of communications between Phibro Animal Health Corporation (PAH) and CVM re: Request for Hearing from Phibro Animal Health Corporation", "Supporting & Related Material", "Background Material", "2016-07-12T04:00:00Z", 2016, 7, null, null, "2016-07-13T16:58:26Z", null, 0, 0, "09000064820a3174"], ["FDA-2016-N-0832-0029", "FDA", "FDA-2016-N-0832", "Request for Hearing from Phibro Animal Health Corporation", "Other", "Request for Hearing", "2016-07-12T04:00:00Z", 2016, 7, "2016-04-12T04:00:00Z", "2016-07-12T03:59:59Z", "2016-07-13T16:04:37Z", null, 0, 0, "09000064820a1fdb"], ["FDA-2016-N-0832-0027", "FDA", "FDA-2016-N-0832", "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed; Opportunity for Hearing; Correction", "Notice", "Meeting", "2016-04-21T04:00:00Z", 2016, 4, "2016-04-21T04:00:00Z", null, "2016-04-21T15:22:46Z", "2016-09265", 0, 0, "0900006481f7cd6a"], ["FDA-2016-N-0832-0026", "FDA", "FDA-2016-N-0832", "Request for Hearing from Phibro Animal Health Corporation", "Other", "Request for Hearing", "2016-04-19T04:00:00Z", 2016, 4, "2016-04-19T04:00:00Z", null, "2016-04-19T14:38:49Z", null, 0, 0, "0900006481f6c57f"], ["FDA-2016-N-0832-0025", "FDA", "FDA-2016-N-0832", "Reference List re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-15T04:00:00Z", 2016, 4, null, null, "2016-04-15T14:18:36Z", null, 0, 0, "0900006481f6c898"], ["FDA-2016-N-0832-0024", "FDA", "FDA-2016-N-0832", "FDA Memorandum regarding the Separation of Functions for Carbadox", "Other", "Memorandum", "2016-04-13T04:00:00Z", 2016, 4, "2016-04-13T04:00:00Z", null, "2016-04-13T15:08:39Z", null, 0, 0, "0900006481f65aca"], ["FDA-2016-N-0832-0013", "FDA", "FDA-2016-N-0832", "Reference 12 FDA Memorandum dtd. July 29, 1975 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:44:51Z", null, 0, 0, "0900006481f56773"], ["FDA-2016-N-0832-0019", "FDA", "FDA-2016-N-0832", "Reference 18 Report, 28th Codex Session, Rome, 2005 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:48:05Z", null, 0, 0, "0900006481f5677e"], ["FDA-2016-N-0832-0023", "FDA", "FDA-2016-N-0832", "Reference 22 FDA Memorandum dtd. July 29, 2012 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:50:07Z", null, 0, 0, "0900006481f56782"], ["FDA-2016-N-0832-0017", "FDA", "FDA-2016-N-0832", "Reference 16 FOI Summary for sNADA 041-061, approved Oct. 5, 1998 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:46:54Z", null, 0, 0, "0900006481f56777"], ["FDA-2016-N-0832-0004", "FDA", "FDA-2016-N-0832", "Reference 3 FDA Memorandum dtd. Mar. 17, 2014 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:40:35Z", null, 0, 0, "0900006481f56d1d"], ["FDA-2016-N-0832-0006", "FDA", "FDA-2016-N-0832", "Reference 5 Baars, A.J., et al., 1990 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:41:29Z", null, 0, 0, "0900006481f56d1f"], ["FDA-2016-N-0832-0008", "FDA", "FDA-2016-N-0832", "Reference 7 CVM GFI #3, July 25, 2006 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:42:23Z", null, 0, 0, "0900006481f5676e"], ["FDA-2016-N-0832-0009", "FDA", "FDA-2016-N-0832", "Reference 8 FDA Memorandum dtd. Sept. 22, 1972 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:42:50Z", null, 0, 0, "0900006481f5676f"], ["FDA-2016-N-0832-0014", "FDA", "FDA-2016-N-0832", "Reference 13 Citizen Petition, FDA Docket No. 86P-0212, May 9, 1986 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:45:23Z", null, 0, 0, "0900006481f56774"], ["FDA-2016-N-0832-0010", "FDA", "FDA-2016-N-0832", "Reference 9 FDA Memorandum dtd. Aug. 27, 1970 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:43:25Z", null, 0, 0, "0900006481f56770"], ["FDA-2016-N-0832-0012", "FDA", "FDA-2016-N-0832", "Reference 11 FDA Memorandum dtd. July 7, 1972 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:44:24Z", null, 0, 0, "0900006481f56772"], ["FDA-2016-N-0832-0002", "FDA", "FDA-2016-N-0832", "Reference 1 FOI Summary for sNADA 041-061, approved Jan. 30, 1998 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:39:41Z", null, 0, 0, "0900006481f56d1b"], ["FDA-2016-N-0832-0022", "FDA", "FDA-2016-N-0832", "Reference 21 CVM GFI #208 - VICH GL49, Sept. 15, 2011 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:49:39Z", null, 0, 0, "0900006481f56781"], ["FDA-2016-N-0832-0015", "FDA", "FDA-2016-N-0832", "Reference 14 Response to Citizen Petition, FDA Docket No. 86P-0212, May 30, 1995 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:45:52Z", null, 0, 0, "0900006481f56775"], ["FDA-2016-N-0832-0018", "FDA", "FDA-2016-N-0832", "Reference 17 FOI Summary for oNADA 141-211, approved July 21, 2004 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:47:23Z", null, 0, 0, "0900006481f5677d"], ["FDA-2016-N-0832-0007", "FDA", "FDA-2016-N-0832", "Reference 6 Baars, A.J., et al., 1991 Residues of Carbadox Metabolites in Edible Pork Products re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:41:56Z", null, 0, 0, "0900006481f56d20"], ["FDA-2016-N-0832-0011", "FDA", "FDA-2016-N-0832", "Reference 10 1990 JECFA report carbadox re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:43:56Z", null, 0, 0, "0900006481f56771"], ["FDA-2016-N-0832-0001", "FDA", "FDA-2016-N-0832", "Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Notice", "Notice of Opportunity of Hearing", "2016-04-12T04:00:00Z", 2016, 4, "2016-04-12T04:00:00Z", "2016-07-12T03:59:59Z", "2020-08-14T15:22:11Z", "2016-08327", 0, 0, "0900006481f61268"], ["FDA-2016-N-0832-0016", "FDA", "FDA-2016-N-0832", "Reference 15 FDA Memorandum dtd. Sept. 7, 1994 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:46:25Z", null, 0, 0, "0900006481f56776"], ["FDA-2016-N-0832-0021", "FDA", "FDA-2016-N-0832", "Reference 20 Macintosh, A.I., et al., 1985 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:49:11Z", null, 0, 0, "0900006481f56780"], ["FDA-2016-N-0832-0005", "FDA", "FDA-2016-N-0832", "Reference 4 Boison, J.O., et al., 2009 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:41:01Z", null, 0, 0, "0900006481f56d1e"], ["FDA-2016-N-0832-0020", "FDA", "FDA-2016-N-0832", "Reference 19 CVM GFI #205 VICH GL46, Sept. 15, 2011 re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:48:34Z", null, 0, 0, "0900006481f5677f"], ["FDA-2016-N-0832-0003", "FDA", "FDA-2016-N-0832", "Reference 2 2003 JECFA report on carbadox re Phibro Animal Health Corp.; Carbadox in Medicated Swine Feed;  Opportunity for Hearing", "Supporting & Related Material", "Background Material", "2016-04-12T04:00:00Z", 2016, 4, null, null, "2016-04-15T13:40:07Z", null, 0, 0, "0900006481f56d1c"]], "truncated": false, "filtered_table_rows_count": 72, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2016-N-0832"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832", "results": [{"value": "FDA", "label": "FDA", "count": 72, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-N-0832", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 38, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 30, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832", "results": [{"value": 2016, "label": 2016, "count": 45, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&posted_year=2016", "selected": false}, {"value": 2017, "label": 2017, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&posted_year=2017", "selected": false}, {"value": 2020, "label": 2020, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&posted_year=2020", "selected": false}, {"value": 2018, "label": 2018, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&posted_year=2018", "selected": false}, {"value": 2019, "label": 2019, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&posted_year=2019", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0832&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 428.0690649757162, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}